BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 36040373)

  • 1. High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant Vulnerabilities.
    Roh W; Geffen Y; Cha H; Miller M; Anand S; Kim J; Heiman DI; Gainor JF; Laird PW; Cherniack AD; Ock CY; Lee SH; Getz G;
    Cancer Res; 2022 Nov; 82(21):3917-3931. PubMed ID: 36040373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Resolution Profiling of Head and Neck Squamous Cells Carcinoma Identifies Specific Biomarkers and Expression Subtypes of Clinically Relevant Vulnerabilities.
    Zhu Y; Peng B; Luo X; Sun W; Liu D; Li N; Qiu P; Long G
    Curr Med Chem; 2024; 31(17):2431-2448. PubMed ID: 37936459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel subtype based on driver methylation-transcription in lung adenocarcinoma.
    Wang X; Xu Z; Zhao S; Song J; Yu Y; Yang H; Hou Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):269. PubMed ID: 38777866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics-based clustering of lung adenocarcinoma identifies three subtypes with significantly different clinical and molecular features.
    Long R; Abulimiti N; Wang X
    Clin Transl Oncol; 2024 Feb; 26(2):538-548. PubMed ID: 37603150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications.
    Hijazo-Pechero S; Alay A; Cordero D; Marín R; Vilariño N; Palmero R; Brenes J; Montalban-Casafont A; Nadal E; Solé X
    Mol Oncol; 2024 Feb; 18(2):453-470. PubMed ID: 37943164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.
    Gillette MA; Satpathy S; Cao S; Dhanasekaran SM; Vasaikar SV; Krug K; Petralia F; Li Y; Liang WW; Reva B; Krek A; Ji J; Song X; Liu W; Hong R; Yao L; Blumenberg L; Savage SR; Wendl MC; Wen B; Li K; Tang LC; MacMullan MA; Avanessian SC; Kane MH; Newton CJ; Cornwell M; Kothadia RB; Ma W; Yoo S; Mannan R; Vats P; Kumar-Sinha C; Kawaler EA; Omelchenko T; Colaprico A; Geffen Y; Maruvka YE; da Veiga Leprevost F; Wiznerowicz M; Gümüş ZH; Veluswamy RR; Hostetter G; Heiman DI; Wyczalkowski MA; Hiltke T; Mesri M; Kinsinger CR; Boja ES; Omenn GS; Chinnaiyan AM; Rodriguez H; Li QK; Jewell SD; Thiagarajan M; Getz G; Zhang B; Fenyö D; Ruggles KV; Cieslik MP; Robles AI; Clauser KR; Govindan R; Wang P; Nesvizhskii AI; Ding L; Mani DR; Carr SA;
    Cell; 2020 Jul; 182(1):200-225.e35. PubMed ID: 32649874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma.
    Xie L; Kong H; Yu J; Sun M; Lu S; Zhang Y; Hu J; Du F; Lian Q; Xin H; Zhou J; Wang X; Powell CA; Hirsch FR; Bai C; Song Y; Yin J; Yang D
    Clin Transl Med; 2024 Feb; 14(2):e1573. PubMed ID: 38318637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiomic investigation of lung adenocarcinoma molecular subtypes.
    Liang KH; Luo YH; Wang ML; Chiou SH; Chen YM; Hsu HS
    J Chin Med Assoc; 2024 Jan; 87(1):33-39. PubMed ID: 37991388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analyses identify HK1 and ATP5A to be overexpressed in distant metastases of lung adenocarcinomas compared to matched primary tumors.
    Pasternack H; Polzer M; Gemoll T; Kümpers C; Sauer T; Lazar-Karsten P; Hinrichs S; Bohnet S; Perner S; Dressler FF; Kirfel J
    Sci Rep; 2023 Nov; 13(1):20948. PubMed ID: 38016997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma.
    Zhang Y; Fu F; Zhang Q; Li L; Liu H; Deng C; Xue Q; Zhao Y; Sun W; Han H; Gao Z; Guo C; Zheng Q; Hu H; Sun Y; Li Y; Ding C; Chen H
    Cell Rep Med; 2024 Jan; 5(1):101358. PubMed ID: 38183982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
    Liu Q; Zhang J; Guo C; Wang M; Wang C; Yan Y; Sun L; Wang D; Zhang L; Yu H; Hou L; Wu C; Zhu Y; Jiang G; Zhu H; Zhou Y; Fang S; Zhang T; Hu L; Li J; Liu Y; Zhang H; Zhang B; Ding L; Robles AI; Rodriguez H; Gao D; Ji H; Zhou H; Zhang P
    Cell; 2024 Jan; 187(1):184-203.e28. PubMed ID: 38181741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative Multianalytical Model Based on Novel Plasma Protein Biomarkers for Distinguishing Lung Adenocarcinoma and Benign Pulmonary Nodules.
    Zhang X; Ji L; Liu M; Li J; Sun H; Liang F; Zhao Y; Wang Z; Yang T; Wang Y; Si Q; Du R; Dai L; Ouyang S
    J Proteome Res; 2024 Jan; 23(1):277-288. PubMed ID: 38085828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically conserved genomic subtypes of gastric adenocarcinoma.
    Jeong YS; Eun YG; Lee SH; Kang SH; Yim SY; Kim EH; Noh JK; Sohn BH; Woo SR; Kong M; Nam DH; Jang HJ; Lee HS; Song S; Oh SC; Lee J; Ajani JA; Lee JS
    Mol Cancer; 2023 Sep; 22(1):147. PubMed ID: 37674200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma.
    Huang Y; Ma S; Xu JY; Qian K; Wang Y; Zhang Y; Tan M; Xiao T
    Clin Proteomics; 2024 Jan; 21(1):2. PubMed ID: 38182978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer proteogenomics characterization of tumor immunity.
    Petralia F; Ma W; Yaron TM; Caruso FP; Tignor N; Wang JM; Charytonowicz D; Johnson JL; Huntsman EM; Marino GB; Calinawan A; Evangelista JE; Selvan ME; Chowdhury S; Rykunov D; Krek A; Song X; Turhan B; Christianson KE; Lewis DA; Deng EZ; Clarke DJB; Whiteaker JR; Kennedy JJ; Zhao L; Segura RL; Batra H; Raso MG; Parra ER; Soundararajan R; Tang X; Li Y; Yi X; Satpathy S; Wang Y; Wiznerowicz M; González-Robles TJ; Iavarone A; Gosline SJC; Reva B; Robles AI; Nesvizhskii AI; Mani DR; Gillette MA; Klein RJ; Cieslik M; Zhang B; Paulovich AG; Sebra R; Gümüş ZH; Hostetter G; Fenyö D; Omenn GS; Cantley LC; Ma'ayan A; Lazar AJ; Ceccarelli M; Wang P;
    Cell; 2024 Feb; 187(5):1255-1277.e27. PubMed ID: 38359819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma.
    Wang J; Sun N; Kunzke T; Shen J; Zens P; Prade VM; Feuchtinger A; Berezowska S; Walch A
    NPJ Precis Oncol; 2023 Nov; 7(1):114. PubMed ID: 37919427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Ferroptosis Inducers, HDAC, and RTK Inhibitor Sensitivity in Melanoma Subtypes through Unbiased Drug Target Prediction.
    Pla I; Szabolcs BL; Péter PN; Ujfaludi Z; Kim Y; Horvatovich P; Sanchez A; Pawlowski K; Wieslander E; Guedes J; Pál DM; Ascsillán AA; Betancourt LH; Németh IB; Gil J; de Almeida NP; Szeitz B; Szadai L; Doma V; Woldmar N; Bartha Á; Pahi Z; Pankotai T; Győrffy B; Szasz AM; Domont G; Nogueira F; Kwon HJ; Appelqvist R; Kárpáti S; Fenyö D; Malm J; Marko-Varga G; Kemény LV
    bioRxiv; 2024 Feb; ():. PubMed ID: 38545623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological basis of the lung adenocarcinoma subtypes.
    Zha L; Matsu-Ura T; Sluka JP; Murakawa T; Tsuta K
    iScience; 2024 May; 27(5):109742. PubMed ID: 38706836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrated Approach for Identifying Molecular Subtypes in Human Colon Cancer Using Gene Expression Data.
    Wang WH; Xie TY; Xie GL; Ren ZL; Li JM
    Genes (Basel); 2018 Aug; 9(8):. PubMed ID: 30072645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities.
    Sun CX; Daniel P; Bradshaw G; Shi H; Loi M; Chew N; Parackal S; Tsui V; Liang Y; Koptyra M; Adjumain S; Sun C; Chong WC; Fernando D; Drinkwater C; Tourchi M; Habarakada D; Sooraj D; Carvalho D; Storm PB; Baubet V; Sayles LC; Fernandez E; Nguyen T; Pörksen M; Doan A; Crombie DE; Panday M; Zhukova N; Dun MD; Ludlow LE; Day B; Stringer BW; Neeman N; Rubens JA; Raabe EH; Vinci M; Tyrrell V; Fletcher JI; Ekert PG; Dumevska B; Ziegler DS; Tsoli M; Syed Sulaiman NF; Loh AHP; Low SYY; Sweet-Cordero EA; Monje M; Resnick A; Jones C; Downie P; Williams B; Rosenbluh J; Gough D; Cain JE; Firestein R
    Cancer Cell; 2023 Apr; 41(4):660-677.e7. PubMed ID: 37001527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.